FDA.reportPublic FDA data

benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG [Salinocaine]

RxCUI
1603379
RxNorm name
benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG [Salinocaine]
Term type
SBDC
Status
Active
Updated
2026-10-15 15:45:10

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042015
Active start
042015
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.02 MG / 1 MGbenzocaine
0.55 MG / 1 MGsalicylic acid

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
salicylic acid9525

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbenzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG [Salinocaine]1NAMES
RxNorm Namebenzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG [Salinocaine]1NAMES
TTYSBDC1ATTRIBUTES
RxCUI16033791CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCS01BCAntiinflammatory agents, non-steroidsATC1-4salicylic acid
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
ATCD01AEOther antifungals for topical useATC1-4salicylic acid
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD020156Salicylic AcidCHEMhas_ingredientsalicylic acid
MEDRTD000152Acne VulgarisDISEASEmay_treatsalicylic acid
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD017492Keratosis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD011565PsoriasisDISEASEmay_treatsalicylic acid
MEDRTD012536Scalp DermatosesDISEASEmay_treatsalicylic acid
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTD014860WartsDISEASEmay_treatsalicylic acid
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moasalicylic acid
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000009974Increased Skin KeratinizationPEhas_pesalicylic acid

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS